Elevance Health (ELV) Capital Expenditures (2010 - 2026)

Elevance Health (ELV) has 17 years of Capital Expenditures data on file, last reported at $235.0 million in Q1 2026.

• Quarterly Capital Expenditures rose 19.9% year-over-year to $235.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 1.53% YoY) and the FY2025 annual result came in at $1.1 billion, down 11.15% from the prior year.
• Capital Expenditures fell to $235.0 million in Q1 2026 per ELV's latest filing, from $293.0 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $360.0 million in Q3 2025 and bottomed at $196.0 million in Q1 2025.
• The 5-year median for Capital Expenditures is $301.0 million (2023), against an average of $297.4 million.
• The widest annual swing landed in 2022, when Capital Expenditures grew 24.51%; it then retreated 29.75% in 2025.
• Tracing ELV's Capital Expenditures over 5 years: stood at $298.0 million in 2022, then rose by 9.4% to $326.0 million in 2023, then dropped by 1.23% to $322.0 million in 2024, then decreased by 9.01% to $293.0 million in 2025, then retreated by 19.8% to $235.0 million in 2026.
• Per Business Quant, the three latest ELV Capital Expenditures figures stand at $235.0 million (Q1 2026), $293.0 million (Q4 2025), and $360.0 million (Q3 2025).

Peer Comparison